JP4515767B2 - 非標的核酸依存性増幅の低減：反復核酸配列の増幅 - Google Patents

非標的核酸依存性増幅の低減：反復核酸配列の増幅 Download PDF

Info

Publication number
JP4515767B2
JP4515767B2 JP2003564211A JP2003564211A JP4515767B2 JP 4515767 B2 JP4515767 B2 JP 4515767B2 JP 2003564211 A JP2003564211 A JP 2003564211A JP 2003564211 A JP2003564211 A JP 2003564211A JP 4515767 B2 JP4515767 B2 JP 4515767B2
Authority
JP
Japan
Prior art keywords
primer
repeat unit
nucleotide
nucleic acid
target nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003564211A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005515778A5 (enExample
JP2005515778A (ja
Inventor
リチャード・コーソーン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Utah
Original Assignee
University of Utah
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27663226&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP4515767(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University of Utah filed Critical University of Utah
Publication of JP2005515778A publication Critical patent/JP2005515778A/ja
Publication of JP2005515778A5 publication Critical patent/JP2005515778A5/ja
Application granted granted Critical
Publication of JP4515767B2 publication Critical patent/JP4515767B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2003564211A 2002-01-31 2003-01-31 非標的核酸依存性増幅の低減：反復核酸配列の増幅 Expired - Fee Related JP4515767B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35359102P 2002-01-31 2002-01-31
PCT/US2003/002844 WO2003064615A2 (en) 2002-01-31 2003-01-31 Amplifying repetitive nucleic acid sequences

Publications (3)

Publication Number Publication Date
JP2005515778A JP2005515778A (ja) 2005-06-02
JP2005515778A5 JP2005515778A5 (enExample) 2006-03-23
JP4515767B2 true JP4515767B2 (ja) 2010-08-04

Family

ID=27663226

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003564211A Expired - Fee Related JP4515767B2 (ja) 2002-01-31 2003-01-31 非標的核酸依存性増幅の低減：反復核酸配列の増幅

Country Status (9)

Country Link
US (2) US7695904B2 (enExample)
EP (1) EP1476561B1 (enExample)
JP (1) JP4515767B2 (enExample)
CN (1) CN100473723C (enExample)
AT (1) ATE534746T1 (enExample)
AU (1) AU2003208902B2 (enExample)
CA (1) CA2474468C (enExample)
ES (1) ES2379375T3 (enExample)
WO (1) WO2003064615A2 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9944978B2 (en) 2014-12-30 2018-04-17 Telomere Diagnostics, Inc. Multiplex quantitative PCR
US10227649B2 (en) 2003-01-24 2019-03-12 University Of Utah Research Foundation Methods of predicting mortality risk by determining telomere length
US10316366B2 (en) 2013-05-22 2019-06-11 Telomere Diagnostics, Inc. Measures of short telomere abundance
US10450602B2 (en) 2008-12-22 2019-10-22 University Of Utah Research Foundation Monochrome multiplex quantitative PCR

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US8652782B2 (en) * 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
WO2009029686A1 (en) 2007-08-27 2009-03-05 Longhorn Vaccines & Diagnostics Llc Immunogenic compositions and methods
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
DK2195466T3 (da) 2007-10-01 2013-01-14 Longhorn Vaccines & Diagnostics Llc Fremgangsmåde til opbevaring af biologiske prøver
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
CN101230403B (zh) * 2008-02-21 2010-12-29 浙江理工大学 解析染色体端粒g-末端序列的方法
WO2010045245A1 (en) 2008-10-17 2010-04-22 Geron Corporation Method for identification of sensitivity of a patient to telomerase inhibition therapy
US20110207128A1 (en) * 2010-02-16 2011-08-25 Cawthon Richard M Methods and kits for determining biological age and longevity based on gene expression profiles
JP2011223940A (ja) * 2010-04-21 2011-11-10 Asahi Breweries Ltd 偽陰性を排除するｐｃｒ検査方法およびそれに使用するプライマー
WO2012135125A1 (en) 2011-03-28 2012-10-04 Geron Corporation Telomere length measurement in formalin-fixed, paraffin embedded (ffpe) samples by quantitative pcr
WO2013054666A1 (ja) * 2011-10-13 2013-04-18 学校法人 東京女子医科大学 テロメア配列増幅用プライマー
WO2013101290A1 (en) * 2011-12-29 2013-07-04 Qiagen Methods of using telomeres as markers for aging
CN104203272A (zh) 2012-01-26 2014-12-10 长角牛疫苗和诊断有限责任公司 复合抗原序列及疫苗
US20130310269A1 (en) * 2012-05-04 2013-11-21 Austin So Hot-start digital pcr
CA2892445C (en) 2012-11-30 2022-06-28 Geron Corporation Diagnostic markers for treating cell proliferative disorders with telomerase inhibitors
US9200327B2 (en) 2012-11-30 2015-12-01 Geron Corporation Diagnostic markers for treating cell proliferative disorders with telomerase inhibitors
WO2014152937A1 (en) * 2013-03-14 2014-09-25 Ibis Biosciences, Inc. Nucleic acid control panels
WO2014152676A1 (en) * 2013-03-15 2014-09-25 New York University A method for a single cell analysis of telomer length
EP2971134B1 (en) * 2013-03-15 2023-10-25 Aegea Biotechnologies, Inc. Methods for amplifying fragmented target nucleic acids utilizing an assembler sequence
GB201418144D0 (en) * 2014-10-14 2014-11-26 Univ Cardiff High throughput sequencing
WO2016183292A1 (en) 2015-05-14 2016-11-17 Longhorn Vaccines And Diagnostics, Llc Rapid methods for the extraction of nucleic acids from biological samples
US10577643B2 (en) * 2015-10-07 2020-03-03 Illumina, Inc. Off-target capture reduction in sequencing techniques
US10186789B1 (en) 2018-04-13 2019-01-22 Rustcraft Industries LLC Keyed cable and connector system
CN112029841B (zh) 2019-06-03 2024-02-09 香港中文大学 定量端粒长度和基因组基序的方法
US12485166B2 (en) 2020-02-06 2025-12-02 Longhorn Vaccines And Diagnostics, Llc Vaccines for the treatment and prevention of zoonotic infections
KR20230091978A (ko) 2020-10-20 2023-06-23 롱혼 백신즈 앤드 다이어그나스틱스, 엘엘씨 면역원성 항원
CN113862339B (zh) * 2021-12-01 2022-03-22 广州滴纳生物科技有限公司 核酸组合产品、检测试剂盒和扩增靶核酸的方法
CN116218893B (zh) * 2023-03-24 2025-07-29 哈尔滨医科大学 一种通过体外扩增重组质粒在其编码基因上生成短片段串联重复序列的方法
CN117230169B (zh) * 2023-11-13 2024-02-13 元码基因科技（北京）股份有限公司 用于长片段端粒序列测序的接头、预文库及其构建方法
CN117248003B (zh) * 2023-11-13 2024-04-12 元码基因科技（北京）股份有限公司 用于完整端粒扩增子测序的组合物、预文库及其构建方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020124A (en) * 1992-04-27 2000-02-01 Trustees Of Dartmouth College Detection of soluble gene sequences in biological fluids
US5489508A (en) * 1992-05-13 1996-02-06 University Of Texas System Board Of Regents Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
US5512441A (en) * 1994-11-15 1996-04-30 American Health Foundation Quantative method for early detection of mutant alleles and diagnostic kits for carrying out the method
US5741677A (en) * 1995-06-07 1998-04-21 Geron Corporation Methods for measuring telomere length
JP3718892B2 (ja) * 1996-02-05 2005-11-24 三菱化学株式会社 ヒト・テロメラーゼ活性の測定方法
JP4013333B2 (ja) 1998-06-05 2007-11-28 株式会社Ｂ＆Ｃラボラトリーズ 皮膚の老化度の測定方法および測定用キット
US6436677B1 (en) * 2000-03-02 2002-08-20 Promega Corporation Method of reverse transcription

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10227649B2 (en) 2003-01-24 2019-03-12 University Of Utah Research Foundation Methods of predicting mortality risk by determining telomere length
US11193169B2 (en) 2003-01-24 2021-12-07 University Of Utah Research Foundation Methods of predicting mortality risk by determining telomere length
US10450602B2 (en) 2008-12-22 2019-10-22 University Of Utah Research Foundation Monochrome multiplex quantitative PCR
US11168359B2 (en) 2008-12-22 2021-11-09 University Of Utah Research Foundation Monochrome multiplex quantitative PCR
US10316366B2 (en) 2013-05-22 2019-06-11 Telomere Diagnostics, Inc. Measures of short telomere abundance
US9944978B2 (en) 2014-12-30 2018-04-17 Telomere Diagnostics, Inc. Multiplex quantitative PCR

Also Published As

Publication number Publication date
US7695904B2 (en) 2010-04-13
ATE534746T1 (de) 2011-12-15
US20100151477A1 (en) 2010-06-17
US20030162266A1 (en) 2003-08-28
WO2003064615A2 (en) 2003-08-07
CA2474468A1 (en) 2003-08-07
EP1476561B1 (en) 2011-11-23
HK1072275A1 (en) 2005-08-19
CN1639352A (zh) 2005-07-13
JP2005515778A (ja) 2005-06-02
US8048631B2 (en) 2011-11-01
AU2003208902B2 (en) 2008-08-07
ES2379375T3 (es) 2012-04-25
CA2474468C (en) 2014-03-25
WO2003064615A3 (en) 2004-02-26
CN100473723C (zh) 2009-04-01
EP1476561A2 (en) 2004-11-17
EP1476561A4 (en) 2006-08-02

Similar Documents

Publication Publication Date Title
JP4515767B2 (ja) 非標的核酸依存性増幅の低減：反復核酸配列の増幅
US11193169B2 (en) Methods of predicting mortality risk by determining telomere length
AU2003208902A1 (en) Amplifying repetitive nucleic acid sequences
JP6310889B2 (ja) 単色マルチプレックス定量ｐｃｒ
US8206929B2 (en) Nucleic acid amplification with allele-specific suppression of sequence variants
Sathyanarayana et al. Laboratory approaches in molecular pathology: the polymerase chain reaction
EP2758546B1 (en) Use of g-clamp for improved allele-specific pcr
US20130171630A1 (en) Methods of using telomeres as markers for aging
US20070099184A1 (en) Nucleic acid amplication utilizing intermediate duplexes
Aldape et al. Real‐time quantitative polymerase chain reaction: a potential tool for genetic analysis in neuropathology
HK1072275B (en) Amplifying repetitive nucleic acid sequences
CytoScan Genomic Copy Number Findings
HK1173218A (en) Methods of predicting mortality risk by determining telomere length

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060131

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060131

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081007

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090107

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090115

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090203

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090210

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090407

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090507

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090907

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20091016

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091104

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100204

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100212

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100303

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100402

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100427

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100513

R150 Certificate of patent or registration of utility model

Ref document number: 4515767

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130521

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130521

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees